RIVANNA MEDICAL, LLC holds $40.4M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Mar 31, 2027 PoP end — agencies typically plan 12–18 months ahead.
ACCURO XV PRODUCT FOR RAPID, ULTRASOUND BASED, RADIATION-FREE, BEDSIDE FRACTURE TRIAGE. THIS DEVICE WILL REDUCE BOTTLENECKS IN MASS CASUALTY BLAST TRAUMA INCIDENTS.
Current PoP ends Mar 31, 2027 (247 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Track recompete timing in SCOUT →RIVANNA MEDICAL, LLC — $40.4M obligated across 1 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. Free — no card required.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open RIVANNA MEDICAL, LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Register free to start exploring SCOUT →